What is the treatment for Vitamin B1 (Thiamine) deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment for vitamin B1 (thiamine) deficiency involves immediate thiamine supplementation, typically starting with high-dose parenteral (injectable) thiamine for severe cases, followed by oral maintenance therapy, with a recommended dose of 3 x 100-300 mg per day intravenously, as suggested by the most recent and highest quality study 1.

Key Considerations

  • The route of administration can be oral, enteral, or IV, but IV is the most efficient, especially in severe cases 1.
  • Treatment should begin before glucose administration in malnourished patients to prevent precipitating or worsening Wernicke's encephalopathy.
  • The underlying cause of deficiency must also be addressed, whether it's alcoholism, malabsorption disorders, or poor nutrition.

Dosage and Administration

  • For severe deficiency or Wernicke's encephalopathy, the dose and duration of treatment may vary, but the consensus is to start with high-dose parenteral thiamine 1.
  • Oral thiamine at 100-300 mg daily divided into multiple doses is recommended for less severe deficiency 1.

Special Considerations

  • Patients at risk of thiamine deficiency, such as those with prolonged vomiting, rapid weight loss, poor dietary intake, alcohol abuse, or symptoms of neuropathy, should be treated immediately without delay pending blood results 1.
  • All healthcare professionals involved in the aftercare of patients at risk of thiamine deficiency should be aware of the potential risk for severe thiamine deficiency and its symptoms, including ataxia, confusion, coma, neuropathy, and cardiac insufficiency 1.

From the FDA Drug Label

Thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety The treatment for Vitamin B1 (Thiamine) deficiency is thiamine hydrochloride injection, which is used when rapid restoration of thiamine is necessary, such as in:

  • Wernicke’s encephalopathy
  • Infantile beriberi with acute collapse
  • Cardiovascular disease due to thiamine deficiency
  • Neuritis of pregnancy if vomiting is severe 2

From the Research

Treatment for Vitamin B1 Deficiency

The treatment for Vitamin B1 (Thiamine) deficiency is primarily based on the administration of thiamine. Key aspects of treatment include:

  • Dose of thiamine: The optimal dose of thiamine for treatment is not well established, but it is generally recommended to start with a high dose, especially in severe cases 3, 4.
  • Mode of administration: Thiamine can be administered orally or parenterally, with parenteral administration being preferred in severe cases or when oral administration is not possible 5, 6.
  • Timing of treatment: Early treatment is crucial to prevent long-term neurological damage and improve symptoms 4, 7.
  • Use of magnesium: Magnesium is an essential cofactor for thiamine-facilitated enzymatic reactions and may be administered alongside thiamine 3.

Clinical Considerations

Clinical considerations for the treatment of Vitamin B1 deficiency include:

  • High clinical suspicion: A high index of suspicion is necessary to diagnose thiamine deficiency, especially in patients with non-alcoholic causes of deficiency 5, 6.
  • Early therapeutic intervention: Early treatment with thiamine can lead to rapid clinical improvement, even in severe cases 4, 7.
  • Individualized treatment: Treatment should be individualized based on the etiology and severity of the deficiency, as well as the presence of any underlying medical conditions 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Thiamine deficiency disorders: a clinical perspective.

Annals of the New York Academy of Sciences, 2021

Research

Wernicke-Korsakoff syndrome: recognition and treatment.

Nursing standard (Royal College of Nursing (Great Britain) : 1987), 2017

Research

Review of thiamine deficiency disorders: Wernicke encephalopathy and Korsakoff psychosis.

Journal of basic and clinical physiology and pharmacology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.